Kronox Lab Sciences was listed at Rs 164.95 on the National Stock Exchange, a premium of 21.3% to its issue price of Rs 136. 

Kronox Lab Sciences closed its IPO on June 05. The company opened the issue on June 03 with a price band fixed at Rs 129 to 136 per share. 

The company is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. These chemicals are used in various applications such as API manufacturing, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, and many others. 

AI push aiding cloud investments: Wipro report L&T Technology Services signs new long term framework agreement with Shell GAIL shoots up 5% to 52-week highs; Brokerages maintain Buy HP India foresees AI PCs dominating 50% of portfolio in three years

Kronox provides various products ranging up to 185 such as phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, and others. The company not only supplies its products in India but to more than 20 countries across the globe. These countries include the United States, Argentina, Mexico, Australia, Egypt, and Spain among others.

About Kronox Lab Sciences IPO

Kronox Lab Sciences raised Rs 130.15 crore by dumping 9.6 million shares of selling shareholders. Pantomath Capital Advisors was the book-running lead manager and Kfin Technologies registrar.